Introduction: Breast cancer exhibits marked biological heterogeneity, resulting in variable responses to chemotherapy. The lack of accurate predictive biomarkers in clinical practice limits therapeutic personalization and exposes patients to unnecessary toxicities. In this context, circulating microRNAs (miRNAs) have e...
Júlia Vieira Lipert Pazzim, Daisy Crispym, Nathalia Cruz Costa et al.· Mastology· 0 citations
Introduction: Breast cancer progression is a complex process mediated by molecular alterations that precede clinical manifestations. MicroRNAs act as critical post-transcriptional regulators and may play oncogenic or tumor-suppressive roles. The identification of biomarkers that correlate molecular signatures with clin...
Brenda Carrera Merlini, Nathalia Cruz Costa, Julia Lipert Pazzin et al.· Mastology· 0 citations
Introduction: Breast cancer remains the most prevalent malignancy and the leading cause of cancer-related mortality among women in Brazil. Over the past two decades, the healthcare landscape has been transformed by advances in diagnostic approaches and personalized therapies, highlighting the need for longitudinal eval...
Nathalia Cruz Costa, Brenda Carrera Merlini, Júlia Vieira Lipert Pazzim et al.· Mastology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.